Mercury Bio Revenue and Competitors

Santa Fe, NM USA

Location

$4M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mercury Bio's estimated annual revenue is currently $2.5M per year.(i)
  • Mercury Bio's estimated revenue per employee is $155,000
  • Mercury Bio's total funding is $4M.

Employee Data

  • Mercury Bio has 16 Employees.(i)
  • Mercury Bio grew their employee count by 0% last year.

Mercury Bio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
COOReveal Email/Phone
5
COOReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M356%N/AN/A
#2
$1.8M2353%$12.8MN/A
#3
$2.8M18-18%N/AN/A
#4
$2.3M150%N/AN/A
#5
$6.4M415%N/AN/A
#6
$2.5M1633%N/AN/A
#7
$2.5M160%$4.25MN/A
#8
$22.5M1459%N/AN/A
#9
$3.7M24-8%$46.4MN/A
#10
$1.4M90%N/AN/A
Add Company

What Is Mercury Bio?

We want to shift the paradigm in drug delivery systems. \n\nMercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific delivery—targeting only the cells that need therapy and working with the body to bypass immune reactions. \n\nNot only will our technology boost patient outcomes, it will help drug developers quicken products to market by reducing many of the obstacles, delays, and risks encountered by traditional drug delivery systems, spreading the viable reach of new medications in the process.\n\nBy advancing drug efficacy, lowering costs, reducing side effects, and shortening time to market, we aim to unlock the potential of new therapies and help make the world’s most advanced medicines more accessible to everyone.

keywords:N/A

$4M

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M16N/AN/A
#2
$1.5M176%N/A
#3
$2.8M1721%N/A
#4
$3.5M180%N/A
#5
$2.8M19N/AN/A